ArticleTechnology in cancer research & treatment

MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma.

Luca Grisetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.